- Disc Medicine Announces Underwritten Offering of Common Stock
- Disc Medicine Presents Positive Clinical Data Across Portfolio at the European Hematology Association (EHA) 2024 Congress
- Disc Medicine to Participate in the Jefferies Global Healthcare Conference
- Disc Medicine Announces Multiple Presentations Across Portfolio at the European Hematology Association (EHA) 2024 Congress
- Disc Medicine to Participate in the H.C. Wainwright BioConnect Investor Conference
- Disc Medicine Reports First Quarter 2024 Financial Results and Provides Business Update
- Disc Reports Topline Results from Phase 2 AURORA Study of Bitopertin in Patients with Erythropoietic Protoporphyria (EPP)
- Disc Medicine Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
- Disc Medicine to Participate in the Leerink Partners Global Biopharma Conference 2024
- Disc Medicine Expands Leadership Team with Appointment of Industry Veteran Pamela Stephenson, MPH as Chief Commercial Officer
More ▼
Key statistics
On Friday, Disc Medicine Inc (IRON:NMQ) closed at 46.62, 82.11% above the 52 week low of 25.60 set on Apr 01, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 43.97 |
---|---|
High | 46.64 |
Low | 43.97 |
Bid | 40.00 |
Offer | 48.50 |
Previous close | 44.43 |
Average volume | 559.20k |
---|---|
Shares outstanding | 29.64m |
Free float | 24.74m |
P/E (TTM) | -- |
Market cap | 1.32bn USD |
EPS (TTM) | -3.37 USD |
Data delayed at least 15 minutes, as of Jul 05 2024 21:00 BST.
More ▼